Latest Breaking News On - ஹிடேஷ் கோசுவாமி - Page 1 : comparemela.com

Precision Oncology Company 4baseCare launches one-of-its-kind Indian Population Specific Cancer Gene Panel

Bangalore (Karnataka) [India], August 18 (ANI/NewsVoir): 4baseCare, a precision oncology company in India, launched their product - TARGT Indiegene, India's largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1,500 cancer patients across 28 different cancer types. Most of the patients were presented with stage III/IV disease, and presented with disease progression and had exhausted all the options in the standard of care.

Hitesh goswamiAmit duttKumar prabhashIllumina accelerator companyActrec tata memorial centreWhole exomeWhole transcriptomeTata memorial centreIllumina acceleratorMount judi venturesSeason two venturesFirst in venturesMedical oncologistPrincipal investigatorஹிடேஷ் கோசுவாமிஅமித் தத்

4baseCare partners with Wipro for personalised oncology solutions

4baseCare partners with Wipro for personalised oncology solutions
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Hitesh goswamiஹிடேஷ் கோசுவாமி

Illumina-backed 4baseCare partners with Wipro for cancer care

Illumina-backed 4baseCare partners with Wipro for cancer care
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Supriyo dasHitesh goswamiRd labPrecision oncologyIllumina acceleratorVice presidentசுப்ரியோ தாஸ்ஹிடேஷ் கோசுவாமிர்ட் ஆய்வகம்ப்ரிஸிஶந் புற்றுநோயியல்இல்லுமின முடுக்குப்பொறிதுணை ப்ரெஸிடெஂட்

Precision Oncology start-up 4baseCare raises $ 2m in pre-series A round from a consortium of venture capital firms

Share this article BANGALORE, India, March 11, 2021 /PRNewswire/ 4baseCare, an Illumina Accelerator backed precision oncology start-up, has raised an investment of USD 2M, led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors. The investor group has a strong understanding of healthcare & technology and focuses on creating social impact through their investments. Hitesh Goswami and Kshitij Rishi 4baseCare aims to make precision oncology a standard of care in Asia by increasing the utilization of genomic tests in oncology and is working towards developing a first of its kind, Indian population specific gene panel that will analyze a large number of genes for cancer-associated mutations to identify optimal treatment options leading to improved outcomes.

United statesHitesh goswamiSajan pillaiSherif kottapurathSun microsystemsDepartment of science technologyMount judi india growth fundManaging partnerSeason two venturesJudi venturesMad street denTwo venturesSouthern californiaGlobal genomicsIllumina acceleratorஒன்றுபட்டது மாநிலங்களில்

4baseCare Raises $2 Mn In Pre-Series A Round

Opinions expressed by You re reading Entrepreneur India, an international franchise of Entrepreneur Media. Illumina accelerator-backed precision oncology startup 4baseCare announced on Thursday to have raised an investment of $2 million in a pre-Series A funding round led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures, and a few strategic angel investors. The company will utilize the funds for expansion of the genomic tests portfolio and for increasing its geographical presence across Asia. Additionally, it will also focus on strengthening its R&D and operations. “Access to advanced technology, which can help improve treatment and care should be for everyone. Our vision is to leverage on technology to develop affordable solutions to personalize patient care in Oncology,” said Hitesh Goswami, chief executive officer, 4baseCare.

United statesHitesh goswamiSherif kottapurathMount judi india growth fundEntrepreneur indiaMount judi venturesSeason two venturesFirst in venturesKshitij rishiManu rikhyeGlobal genomicsIllumina acceleratorCovid 19Co vidCorona virusஒன்றுபட்டது மாநிலங்களில்